MERIT Webinar: PCWG3 and Oncology Imaging Endpoints
Prostate cancer is one of the most common cancer types in men. With bone as a frequent metastatic site, response assessments for prostate cancer have additional considerations beyond RECIST 1.1. In our recorded webinar, MERIT outlines the fundamentals of PCWG3 response criteria, data collection, and response assessment using PSMA scan in prostate cancer. 3 key questions that are answered: 1. Which imaging modalities are used for prostate cancer assessment? 2. What are the fundamentals of PCWG3 response criteria and data collection? 3. How is PSMA being used for newer imaging modalities and response assessments?

▶︎
Inside the National Sample Survey of Registered Nurses (NSSRN) Webinar

▶︎
Antineoplastic Agents | Clinical Medicine

▶︎
Clinical Case Discussions in Ocular Surface Disease with Dr. Laura McLaughlin

▶︎
Effective Reader Monitoring Plans & Variability QC for ADC, IO, CAR-T & Radiopharmaceutical Studies

▶︎
PET RANO 1.0 Webinar: A Framework for Metabolic Response Assessment in Diffuse Glioma

▶︎
Webinar | Top Trends in Background Screening 2025

▶︎
Constangy Webinar Under the Microscope: How High-Profile Investigation Failures Shape Best Practices

▶︎
NestJS Full Course for Beginners in 2026 | Build a Production-Ready API

▶︎
Next-Generation Neuromodulation: Precision, Personalization & Outcomes

▶︎
How to Close the Supplier Truth Gap for Board-Level Confidence in Supplier Data ft The Hackett Group

▶︎
Whole Person Care During and After Pregnancy

▶︎
CNS Infections | Clinical Medicine

▶︎
The Management and Treatment of Merkel Cell Carcinoma

▶︎
Medical Grand Rounds "Congestive Heart Failure"

▶︎
The Complete Cardiology Masterclass: Exam-Ready in One Video

▶︎
2022 Surgical Updates for the Gastric Cancer Patient Webinar

▶︎
MERIT Webinar: RECIST 1.1 & Oncology Trial Endpoints

▶︎
Exploring Alpha-Synuclein Skin Biopsy: The Syn-One Test® w/ CND Life Sciences

▶︎
Fertility Preservation - 1115 Demonstration Waiver Amendment, NVHA Public Meeting

▶︎
